Rebecca L Horan

This inventor holds 22 USPTO granted patents and 26 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Silk Biomaterials. Top assignees: Allergan, Inc., Silk Therapeutics, Inc., Evolved by Nature, Inc.. Active years: 2005-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rebecca L Horan. Retrieved from https://idiyas.com/inventor/rebecca-l-horan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 26)

% Patents Active = 77.3

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 4.7

ph-index = 12

Forward Citations = 559(Granted Patents)

Location History:

Westfield, MA (US) (2005)
Arlington, VA (US) (2014)
Arlington, MA (US) (2012 - 2017)
Needham, MA (US) (2020)

Company Filing History:

Silk Therapeutics, Inc.

patents

1 out of 26

Evolved by Nature, Inc.

patents

4. 1 out of 1

Tissue Regeneration, Inc.

where one patent can have more than one assignee

Years Active: 2005-2020

Loading Chart...

Areas of Expertise:

Silk Fibroin

Pharmaceutical Formulations

Hydrogels

Soft Tissue Replacement

Biocompatible Fabrics

Cell Ingrowth

Tissue Engineering

Dermal Fillers

Biodegradable Fabrics

Silk Protein Fragments

Sericin Fabrics

Implantable Devices

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10588843 - Stable silk fibroin based pharmaceutical formulations (2020-03-17),

2. 9545369 - Stable silk protein fragment compositions (2017-01-17),

3. 9522108 - Stable silk protein fragment compositions (2016-12-20),

4. 9522107 - Stable silk protein fragment compositions (2016-12-20),

5. 9517191 - Stable silk protein fragment compositions (2016-12-13),

6. 9511012 - Stable silk protein fragment compositions (2016-12-06),

7. 9187538 - Stable silk protein fragment compositions (2015-11-17),

8. 9150668 - Silk fibroin hydrogels and uses thereof (2015-10-06),

9. 9089501 - Sericin extracted fabrics (2015-07-28),

10. 9066884 - Sericin extracted fabrics (2015-06-30),

11. 9005606 - Silk fibroin hydrogels and uses thereof (2015-04-14),

12. 8926963 - Compositions and soft tissue replacement methods (2015-01-06),

13. 8900571 - Compositions and soft tissue replacement methods (2014-12-02),

14. 8894992 - Compositions and soft tissue replacement methods (2014-11-25),

15. 8741281 - Compositions and soft tissue replacement methods (2014-06-03),

Title: Rebecca L. Horan: Innovator in Silk-Based Pharmaceuticals

Introduction

Rebecca L. Horan, based in Arlington, MA, is a distinguished inventor with an impressive portfolio of 22 patents. Her innovative work primarily focuses on silk fibroin-based pharmaceutical formulations, which have the potential to revolutionize the field of drug delivery and therapeutics.

Latest Patents

Among her latest patents, Rebecca has developed compositions that encompass pure silk fibroin-based protein fragments, which are notably devoid of sericin. These compositions exhibit a molecular weight range from about 17 kDa to about 38 kDa and demonstrate a polydispersity between 1.5 and 3.0. The formulations are designed to be substantially homogeneous and maintain low levels of inorganic and organic residuals, ranging from 0 ppm to about 500 ppm. This innovative approach highlights the versatility and stability of silk proteins in pharmaceutical applications.

Career Highlights

Rebecca has made significant contributions to companies such as Allergan, Inc. and Silk Therapeutics, Inc. Her work has been pivotal in advancing the use of silk proteins in therapeutic formulations, enabling improved biocompatibility and efficacy in drug delivery systems.

Collaborations

Throughout her career, Rebecca has collaborated with talented professionals, including Gregory H. Altman and Jingsong Chen. Their collective expertise has fostered a dynamic environment for innovation and research in the application of silk proteins.

Conclusion

Rebecca L. Horan stands out as a leading inventor in the realm of silk-based pharmaceuticals. Her groundbreaking patents and collaborations underscore her commitment to advancing scientific knowledge and developing innovative solutions in healthcare. Her work promises to pave the way for new therapeutic possibilities, significantly impacting the pharmaceutical landscape.

Profile summary based on public USPTO records.